Eli Lilly breaks ground on $3.5 billion injectable drug plant in Pennsylvania
Full story
Eli Lilly has started building a new injectable drug facility in Fogelsville, Pennsylvania. The plant will cover 925,000 square feet. This project is expected to create 850 permanent jobs. The facility aims to increase the capacity of the United States to produce next-generation treatments for obesity. The total investment for the plant is 3.5 billion dollars.
Eli Lilly began construction of a 925,000‑sq‑ft facility in Fogelsville, Pennsylvania, slated to create 850 permanent jobs and boost U.S. capacity for next‑generation obesity treatments.